Home › Funds › Rosalind Advisors, Inc. › OKUR
Rosalind Advisors, Inc. position in OKUR
ONKURE THERAPEUTICS INC-A · Health Care
Rosalind Advisors, Inc. reported holding 150,000 shares of OKUR (ONKURE THERAPEUTICS INC-A) in its Q2 2026 13F filing — a position valued at US$684K, representing 0.25% of its reported portfolio and ranking #29 among its reported holdings. Rosalind Advisors, Inc. has disclosed OKUR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Rosalind Advisors, Inc.'s OKUR position evolved
Rosalind Advisors, Inc. first disclosed a stake in OKUR in Q4 2025 at 730,488 shares (US$2.1M). Across 3 filings, Rosalind Advisors, Inc. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 150,000 shares valued at US$684K — a reduction of -293,763 shares quarter over quarter.. Notable position changes include a 39% trim in Q1 2026 (shares rose 10% over the following quarter), a 66% trim in Q2 2026 (shares fell 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 730.49K | $2.12M | New |
| Q1 2026 | 443.76K | $1.84M | Reduce |
| Q2 2026 | 150.00K | $684.00K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OKUR and 13F data
OKUR (ONKURE THERAPEUTICS INC-A) is a Health Care company. 74 other funds we track also report a position in OKUR — the largest reported positions include BVF INC/IL (US$14.8M), ACORN CAPITAL ADVISORS, LLC (US$12.9M), StepStone Group LP (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OKUR
- BVF INC/IL 3.24M sh · $14.76M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.84M sh · $12.95M · Q2 2026
- StepStone Group LP 2.66M sh · $12.13M · Q2 2026
- ADAR1 Capital Management, LLC 2.24M sh · $10.21M · Q2 2026
- Vivo Capital, LLC 1.93M sh · $8.79M · Q2 2026
- Trails Edge Capital Partners, LP 1.44M sh · $6.56M · Q2 2026
- Sio Capital Management, LLC 1.08M sh · $4.92M · Q2 2026
- Prosight Management, LP 978.99K sh · $4.46M · Q2 2026
- NEA Management Company, LLC 478.55K sh · $2.18M · Q2 2026
- Sofinnova Investments, Inc. 321.69K sh · $1.47M · Q2 2026
- Carlyle Group Inc. 269.89K sh · $1.23M · Q2 2026
- Aisling Capital Management LP 88.61K sh · $404.05K · Q2 2026
More on Rosalind Advisors, Inc.
FAQ
How long has Rosalind Advisors, Inc. held OKUR?
Rosalind Advisors, Inc. has disclosed OKUR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Rosalind Advisors, Inc.'s current position in OKUR?
As of Q2 2026, Rosalind Advisors, Inc. holds 150.00K shares of OKUR (ONKURE THERAPEUTICS INC-A), valued at $684.00K, representing 0.25% of its reported portfolio and ranking #29.
Has Rosalind Advisors, Inc. been buying or selling OKUR?
In the latest 13F filing (Q2 2026), Rosalind Advisors, Inc. reduced its position in OKUR.
Which other funds hold OKUR?
Other major institutional holders of OKUR include BVF INC/IL, ACORN CAPITAL ADVISORS, LLC, StepStone Group LP, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.